Owner Tioga Pharmaceuticals, Inc.

Inventors Jacob, Jutta; Weber, Frank; Barber, Andrew; Gottschlich, Rudolf

Agent Davies Collison Cave

Pub. Number AU-B-2003242527

PCT Number PCT/EP03/04428

PCT Pub. Number WO2003/097051

Priority 02011047.4 17.05.02 EP

Filing date 28 April 2003

Wipo publication date 2 December 2003

Acceptance publication date 23 October 2008

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups